CELL AND GENE THERAPY INSIGHTS

Gene therapy analytics and CMC

April 2025
Gene therapy analytics and CMC

Innovator Insight

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Marc Struhalla, Svenja Michalek
26 March
Read

Webinars

AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques

AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques

Andreja Livk, Sebastijan Peljhan
27 February
Watch
Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Dan Oliver, Ji Hyun Lee
9 April
in 6
Days
Register
Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Ines Goncalves
10 April
in 7
Days
Register
Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

O Stamm, H Ruppach,  Youngkin
15 April
in 12
Days
Register
Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker
30 April
in 27
Days
Register